A single-center study of patients with rare isolated acquired clotting factor deficiencies other than acquired hemophilia A
Rare isolated ACFDs are underestimated, associated with delayed diagnosis, and lack effective therapy. Clinicians should raise awareness for recognizing and managing rare isolated ACFD patients to avoid morbidity and mortality.
Authors
- Xiaofan Liu (ORCID: https://orcid.org/0000-0002-9911-4491)
- Ting Sun (ORCID: https://orcid.org/0000-0003-3997-6062)
- H. Dong (ORCID: https://orcid.org/0000-0002-1783-711X)
- Renchi Yang (ORCID: https://orcid.org/0000-0003-3741-8518)
- Xinyue Dai (ORCID: https://orcid.org/0000-0003-0570-1810)
- Feng Xue (ORCID: https://orcid.org/0000-0002-5947-3924)
- Mankai Ju (ORCID: https://orcid.org/0000-0002-8784-9116)
- Rongfeng Fu (ORCID: https://orcid.org/0000-0001-5442-1028)
- Wei Liu (ORCID: https://orcid.org/0000-0003-4713-2441)
- Lei Zhang (ORCID: https://orcid.org/0000-0001-7769-7377)
- Dandan Yu (ORCID: https://orcid.org/0000-0003-0969-9383)
- Yunfei Chen (ORCID: https://orcid.org/0000-0001-7309-8545)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Institute of Hematology & Blood Diseases Hospital (CN)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.rpth.2024.102554
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- National Key Research and Development Program of China